Cronos Group Inc. (NASDAQ: CRON)

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research technology and product development. The company operates licensed production facilities in Canada and Israel and maintains a diversified brand portfolio that includes Spinach PEACE NATURALS LIT and Lord Jones.

Cronos generates revenue primarily from the sale of cannabis products such as dried flower prerolls vaporizers concentrates edibles and topicals to wholesale customers including provincial cannabis control authorities medical patients and international distributors. The company also earns income from wholesale supply agreements with other licensed producers and from licensing its brand portfolio to third parties.

The company operates through a single consolidated segment that includes its operations in Canada and Israel.

• - Consolidated segment: Includes licensed cannabis production facilities in Canada and Israel comprising the Peace Naturals Campus Cronos GrowCo and Cronos Israel operations which handle cultivation processing distribution and sale of cannabis products.

Cronos holds a competitive position in the global cannabis industry due to its strong brand recognition robust financial backing from its strategic investor and an efficient supply chain. The company competes primarily on product quality cost of production innovation intellectual property and price. Key competitors include other licensed producers in Canada and international markets as well as unregulated illegal operators. Cronos advantages stem from its diversified brand portfolio its focus on research and development and its ability to scale production through its partnership with Cronos GrowCo.

Cronos serves a diverse customer base that includes provincial cannabis control authorities such as the Ontario Cannabis Retail Corporation and the Alberta Gaming Liquor and Cannabis Commission which together accounted for a significant portion of its revenue in 2025. The company also sells to medical patients through pharmacies in Israel and to wholesale distributors in other international markets.